These research results will have impact in 2020
Study assesses outcomes of therapies with novel agents
Autologous anti-CD19 agent produces impressive survival improvements
Interim results of phase 2 trial are promising
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Overly restrictive exclusions may lead to racial disparities and unrealistic outcomes
Study results from ASH 2019 shed light on treatment
Please join our staff as we participate or present in the following sessions at the 61st American Society of Hematology (ASH) Annual Meeting.